Condition: Diabetes Mellitus, Type 2 · Sponsor: Novo Nordisk A/S
This study is comparing the medicine RYBELSUS® to other medicines in people with type 2 diabetes who need extra treatment. All medicines used in this study are tablets which lower blood sugar in people with type 2 diabetes. The purpose of the study is to see how well RYBELSUS® is at lowering blood sugar compared to other tablets when used in addition to metformin. Participants doctor will give participants either RYBELSUS® or any other blood sugar lowering tablets - which treatment participants get is decided by chance. The doctor treating participants diabetes will give participants a prescription for the medicine and tell how to take it. The study will last for about 1 year. Participants will have 2 planned visits with their doctor which are part of the usual routine diabetes management: the first visit is when participants are included in the study, the second visit is a 1-year follow-up visit. In addition, the study personnel will contact participants up to 3 times during this period and to follow-up on information from participant doctors visits. Participant will be asked to respond 3 times to 4 questionnaires via their personal smartphone or tablet or paper if participant do not have access to one during the study. All clinic visits are part of the usual routine diabetes management and are covered by participants health insurance plan. The study team will collect information from these visits recorded in the medical chart. Women cannot take part if pregnant, breast-feed…
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Stewart Medical Group | Alhambra, California, United States | — |
| FDRC | Costa Mesa, California, United States | — |
| Scripps Whittier Diabetes Inst | La Jolla, California, United States | — |
| Raincross Medical Group | Riverside, California, United States | — |
| Reyes Clinical Research, Inc | Miami, Florida, United States | — |
| DC Research Works | Marietta, Georgia, United States | — |
| Urban Family Practice Assoc | Marietta, Georgia, United States | — |
| Macoupin Research Group | Gillespie, Illinois, United States | — |
| UnityPoint Health-Diabetes Care Center | Peoria, Illinois, United States | — |
| Endeavor Health | Skokie, Illinois, United States | — |
| Kernodle Clin Dpt-Pvt Diagnost | Burlington, North Carolina, United States | — |
| OnSite Clinical Solutions, LLC_Charlotte | Charlotte, North Carolina, United States | — |
+ 13 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05035082